Tretinoin 0.05% Lotion for the Once-Daily Treatment of Moderate and Severe Acne Vulgaris in Females: Effect of Age on Efficacy and Tolerability
Stein Gold, L.; Pariser, D.M..; Guenin, E.
Journal of Drugs in Dermatology Jdd 18(12): 1218-1225
2019
ISSN/ISBN: 1545-9616 PMID: 31860209 Document Number: 17997
BACKGROUND: While it is generally considered to be a disease of adolescence, acne affects an increasing number of adults, especially women. Although data exist on the use of retinoids in adult females, there is no universal agreement as to the age of onset of adult female acne, or data on the efficacy and tolerability dependent on age. A novel tretinoin 0.05% lotion formulation has been shown to be effective and well-tolerated in acne patients with moderate or severe disease.
Document emailed within 1 workday
Related Documents
Cook-Bolden, F.E. 2012: Treatment of moderate to severe acne vulgaris in a Hispanic population: a post-hoc analysis of efficacy and tolerability of clindamycin phosphate 1.2%/benzoyl peroxide 2.5% gel Journal of Drugs in Dermatology: Jdd 11(4): 455-459Thiboutot, D.; Gold, M.H.; Jarratt, M.T.; Kang, S.; Kaplan, D.L.; Millikan, L.; Wolfe, J.; Loesche, C.; Baker, M. 2001: Randomized controlled trial of the tolerability, safety, and efficacy of adapalene gel 0.1% and tretinoin microsphere gel 0.1% for the treatment of acne vulgaris Cutis 68(4 Suppl): 10-19
Elsaie, M.L.; Abdelhamid, M.F.; Elsaaiee, L.T.; Emam, H.M. 2009: The efficacy of topical 2% green tea lotion in mild-to-moderate acne vulgaris Journal of Drugs in Dermatology: Jdd 8(4): 358-364
Amar, L.; Kircik, L.H. 2018: Treatment of Moderate Acne Vulgaris in Fitzpatrick Skin Type V or VI: Efficacy and Tolerability of Fixed Combination Clindamycin Phosphate 1.2%/Benzoyl Peroxide 3.75% Gel Journal of Drugs in Dermatology: Jdd 17(10): 1107-1112
Webster, G.F.; Guenther, L.; Poulin, Y.P.; Solomon, B.A.; Loven, K.; Lee, J. 2002: A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris Cutis 69(2 Suppl): 4-11
Callender, V.D. 2012: Fitzpatrick skin types and clindamycin phosphate 1.2%/benzoyl peroxide gel: efficacy and tolerability of treatment in moderate to severe acne Journal of Drugs in Dermatology: Jdd 11(5): 643-648
Kircik, L.H. 2009: Tretinoin microsphere gel pump 0.04% versus tazarotene cream 0.05% in the treatment of mild-to-moderate facial acne vulgaris Journal of Drugs in Dermatology: Jdd 8(7): 650-654
Webster, G.; Rich, P.; Gold, M.H.; Mraz, S.; Calvarese, B.; Chen, D. 2009: Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations Journal of Drugs in Dermatology: Jdd 8(8): 736-743
Zeichner, J.A.; Wong, V.; Linkner, R.V.; Haddican, M. 2013: Efficacy and safety of tretinoin 0.025%/clindamycin phosphate 1.2% gel in combination with benzoyl peroxide 6% cleansing cloths for the treatment of facial acne vulgaris Journal of Drugs in Dermatology: Jdd 12(3): 277-282
Taylor, S.C.; Cook-Bolden, F.E.; McMichael, A.; Downie, J.B.; Rodriguez, D.A.; Alexis, A.F.; Callender, V.D.; Alvandi, N. 2018: Efficacy, Safety, and Tolerability of Topical Dapsone Gel, 7.5% for Treatment of Acne Vulgaris by Fitzpatrick Skin Phototype Journal of drugs in dermatology: JDD 17(2): 160-167
Gold, M.H. 2006: A multicenter efficacy and tolerability evaluation of benzoyl peroxide in a 10% urea vehicle for the treatment of acne vulgaris Journal of Drugs in Dermatology: Jdd 5(5): 442-445
Babaeinejad, S.H.; Fouladi, R.F. 2013: The efficacy, safety and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris; a randomized trial Journal of Drugs in Dermatology: Jdd 12(9): 1033-1038
Babaeinejad, S.H.; Fouladi, R.F. 2013: The efficacy, safety, and tolerability of adapalene versus benzoyl peroxide in the treatment of mild acne vulgaris: a randomized trial Journal of Drugs in Dermatology: Jdd 12(7): 790-794
Green, L.; Kircik, L.H.; Gwazdauskas, J. 2013: Randomized, controlled, evaluator-blinded studies conducted to compare the efficacy and tolerability of 3 over-the-counter acne regimens in subjects with mild or moderate acne Journal of Drugs in Dermatology: Jdd 12(2): 180-185
Goldman, M.P.; Boyce, S.M. 2003: A single-center study of aminolevulinic acid and 417 NM photodynamic therapy in the treatment of moderate to severe acne vulgaris Journal of Drugs in Dermatology: Jdd 2(4): 393-396
Feldman, S.R.; Werner, C.P.; Alió Saenz, A.B. 2013: The efficacy and tolerability of tazarotene foam, 0.1%, in the treatment of acne vulgaris in 2 multicenter, randomized, vehicle-controlled, double-blind studies Journal of Drugs in Dermatology: Jdd 12(4): 438-446
Tanghetti, E.; Dhawan, S.; Green, L.; Del Rosso, J.; Draelos, Z.; Leyden, J.; Shalita, A.; Glaser, D.A.; Grimes, P.; Webster, G.; Barnett, P.; Le Gall, N. 2010: Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris Journal of Drugs in Dermatology: Jdd 9(5): 549-558
Leyden, J.J.; Bruce, S.; Lee, C.S.; Ling, M.; Sheth, P.B.; Stewart, D.M.; Werschler, W.P.; Gilbert, R.D.; Kircik, L. 2013: A randomized, phase 2, dose-ranging study in the treatment of moderate to severe inflammatory facial acne vulgaris with doxycycline calcium Journal of Drugs in Dermatology: Jdd 12(6): 658-663
Gold, M.H.; Biron, J.A.; Boring, M.; Bridges, T.M.; Bradshaw, V.L. 2007: Treatment of moderate to severe inflammatory acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source Journal of Drugs in Dermatology: Jdd 6(3): 319-322
Pariser, D.M.; Green, L.J.; Stein Gold, L.; Sugarman, J.L.; Lin, T.; Pillai, R. 2018: Halobetasol 0.01%/Tazarotene 0.045% Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: Maintenance of Therapeutic Effect After Cessation of Therapy Journal of Drugs in Dermatology: Jdd 17(7): 723-726